When is Longbio B's IPO?

Longbio B's IPO is currently expected around Jun 4, 2026 on SEHK. IPO dates can move until the company files and prices the offering, so we keep this page updated as new details are confirmed.

What is Longbio B's expected IPO price?

Longbio B's IPO price has not been set yet. The price range is usually disclosed in the final prospectus, shortly before the company lists.

Is Longbio B publicly traded?

Not yet — Longbio B is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Longbio B's pre-IPO price and IPO date will appear here as soon as they're available.

All companies

Longbio B

01779

IPO Upcoming

IPO UpcomingHong Kong(SEHK)0 markets

Official IPO

Priced· SEHK· Listing market: Hong Kong

IPO date

Jun 4, 2026

Final IPO price

To be announced

Shares offered

To be announced

IPO raise

To be announced

Sources: hkex

No live market is quoted for Longbio B yet. Get in line for IPO-day access through a broker in the meantime.

eToro

Invest in stocks once they list with eToro

Trade stocks, ETFs and crypto from one simple account.

Start with eToro

About Longbio B

Longbio B is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.

What the company does

Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.

Business profile

Longbio B belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.

Latest Longbio B IPO news

Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.

Announcement of Allotment Results (LONGBIO-B, 01779)

HKEX (HKEXNews)Jun 4, 2026IPO filing

HKEXNews published the allotment-results announcement for LONGBIO-B (01779), showing final offer price of HK$96.06 and Hong Kong public offering subscriptions totaling 266,377 applications with 28,057 successful and a subscription level of 4,762.58x; dealings were set to commence June 5, 2026.

LONGBIO-B IPO Subscription Results Announcement

BBXJun 3, 2026IPO filing

BBX published LONGBIO-B (01779.HK) IPO subscription results on June 3, 2026, listing 215 applicants with 2,405 total lots subscribed and 5 successful applicants receiving 5 allotted lots.

Longbio B IPO — frequently asked questions

When is Longbio B's IPO?: Longbio B's IPO is currently expected around Jun 4, 2026 on SEHK. IPO dates can move until the company files and prices the offering, so we keep this page updated as new details are confirmed.
What is Longbio B's expected IPO price?: Longbio B's IPO price has not been set yet. The price range is usually disclosed in the final prospectus, shortly before the company lists.
Is Longbio B publicly traded?: Not yet — Longbio B is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Longbio B's pre-IPO price and IPO date will appear here as soon as they're available.